Seer, Sciex to provide end-to-end proteomics solutions

By The Science Advisory Board staff writers

March 30, 2021 -- Sciex and Seer have inked a nonexclusive commercial agreement. Under the deal, Seer will market Sciex's mass spectrometry systems together with its Proteograph product suite.

The firms believe that the combination will yield end-to-end proteomics workflows for labs of all types. Seer's Proteograph product suite includes proprietary engineered nanoparticles, consumables, an automation instrument, and software that enables proteomics studies.

Adding Sciex systems will bring new options for customers to add unbiased proteomics analysis to their studies, according to the companies. Existing proteomics labs can also expand their application set with the combined offering, Seer and Sciex said.

Sciex acquires Intabio
Sciex has acquired Intabio, developer of the Blaze system for biotherapeutic analysis and quality assessment. The Blaze system enables direct coupling...
Sciex, 908 Devices launch biotherapeutics characterization platform
Sciex and 908 Devices have made the ZipChip platform for Sciex mass spectrometers available to the public. This platform expands mass spectrometers from...

Copyright © 2021 scienceboard.net


Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter